| Home > Publications Database > Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment. > Access to Fulltext |
DZNE-2025-00286
|
|||||||
| version 1 |
| ||||||
| Restricted | ||||
DZNE-2025-00286 SUP
|
||||
| version 1 |
| |||